Wednesday, 05 Nov 2025

Navigating Relapse and Sequencing Treatment After BTK Inhibitors in MCL

Written by
Cancer Network
Published
Peter Martin, MD, discusses the complexities of treating relapsed MCL after treatment with a BTK inhibitor.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago